In Vivo Imaging in Pharmaceutical Development and Its Impact on the 3Rs
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
In Vivo Imaging in Pharmaceutical Development and Its Impact on the 3Rs
Authors
Keywords
-
Journal
ILAR JOURNAL
Volume 57, Issue 2, Pages 212-220
Publisher
Oxford University Press (OUP)
Online
2017-01-04
DOI
10.1093/ilar/ilw019
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Innovation in the pharmaceutical industry: New estimates of R&D costs
- (2016) Joseph A. DiMasi et al. JOURNAL OF HEALTH ECONOMICS
- 2015 FDA drug approvals
- (2016) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Fluorescence guided resection (FGR): A primer for oncology
- (2016) Ron R. Allison Photodiagnosis and Photodynamic Therapy
- Discovery of [ 11 C ] MK - 8193 as a PET tracer to measure target engagement of phosphodiesterase 10A (PDE10A) inhibitors
- (2015) Christopher D. Cox et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- New developments in optical coherence tomography
- (2015) Tigran Kostanyan et al. CURRENT OPINION IN OPHTHALMOLOGY
- Preclinical Characterization of the Phosphodiesterase 10A PET Tracer [11C]MK-8193
- (2015) Eric D. Hostetler et al. MOLECULAR IMAGING AND BIOLOGY
- Hepatic Phospholipidosis Is Associated with Altered Hepatobiliary Function as Assessed by Gadoxetate Dynamic Contrast–enhanced Magnetic Resonance Imaging
- (2015) Stephen C. Lenhard et al. TOXICOLOGIC PATHOLOGY
- Magnetic resonance imaging assessment of the ventricular system in the brains of adult and juvenile beagle dogs treated with posaconazole IV Solution
- (2015) C.D.G. Hines et al. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
- A Quantitative Volumetric Micro-Computed Tomography Method to Analyze Lung Tumors in Genetically Engineered Mouse Models
- (2015) Brian B. Haines et al. NEOPLASIA
- 89Zr-trastuzumab and 89Zr-bevacizumab PET to Evaluate the Effect of the HSP90 Inhibitor NVP-AUY922 in Metastatic Breast Cancer Patients
- (2014) S. B. M. Gaykema et al. CLINICAL CANCER RESEARCH
- Radioligand development for molecular imaging of the central nervous system with positron emission tomography
- (2014) Michael Honer et al. DRUG DISCOVERY TODAY
- Clinical development success rates for investigational drugs
- (2014) Michael Hay et al. NATURE BIOTECHNOLOGY
- Retinal Toxicity Induced by a Novel β-secretase Inhibitor in the Sprague-Dawley Rat
- (2014) Mark R. Fielden et al. TOXICOLOGIC PATHOLOGY
- Micro-computed tomography imaging and analysis in developmental biology and toxicology
- (2013) L. David Wise et al. BIRTH DEFECTS RESEARCH PART C-EMBRYO TODAY-REVIEWS
- Effect of odanacatib on bone turnover markers, bone density and geometry of the spine and hip of ovariectomized monkeys: A head-to-head comparison with alendronate
- (2013) Donald S. Williams et al. BONE
- Phase II and Phase III attrition rates 2011–2012
- (2013) John Arrowsmith et al. NATURE REVIEWS DRUG DISCOVERY
- Advances in Fluorescence and Bioluminescence Imaging
- (2012) Takeaki Ozawa et al. ANALYTICAL CHEMISTRY
- Lack of efficacy of L-759274, a novel neurokinin 1 (substance P) receptor antagonist, for the treatment of generalized anxiety disorder
- (2012) David Michelson et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Dynamic contrast-enhanced MRI in clinical trials of antivascular therapies
- (2012) James P. B. O'Connor et al. Nature Reviews Clinical Oncology
- The novel phosphodiesterase 10A inhibitor THPP-1 has antipsychotic-like effects in rat and improves cognition in rat and rhesus monkey
- (2012) Sean M. Smith et al. NEUROPHARMACOLOGY
- Efficacious Intermittent Dosing of a Novel JAK2 Inhibitor in Mouse Models of Polycythemia Vera
- (2012) Manfred Kraus et al. PLoS One
- Development of aprepitant, the first neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting
- (2011) Richard Hargreaves et al. Annals of the New York Academy of Sciences
- PDE10A Inhibitors: Novel Therapeutic Drugs for Schizophrenia
- (2011) Jan Kehler et al. CURRENT PHARMACEUTICAL DESIGN
- Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacological principles toward improving Phase II survival
- (2011) Paul Morgan et al. DRUG DISCOVERY TODAY
- Micro-computed tomographic evaluation of fetal skeletal changes induced by all-trans-retinoic acid in rats and rabbits
- (2010) L. David Wise et al. BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY
- Novel Luciferase-Based Reporter System to Monitor Activation of ErbB2/Her2/neu Pathway Noninvasively During Radiotherapy
- (2010) Frank Wolf et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- How to improve R&D productivity: the pharmaceutical industry's grand challenge
- (2010) Steven M. Paul et al. NATURE REVIEWS DRUG DISCOVERY
- Cardiovascular Applications of Phase-Contrast MRI
- (2009) Monvadi B. Srichai et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Real-time bioluminescence imaging of polycythemia vera development in mice
- (2009) Yanhong Ma et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Heat Shock Protein 90 as a Drug Target: Some Like It Hot
- (2008) U. Banerji CLINICAL CANCER RESEARCH
- What we can do and what we cannot do with fMRI
- (2008) Nikos K. Logothetis NATURE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started